Therapy of heart failure

Current Opinion in Investigational Drugs

Volumn 2, Issue 1, 2001, Pages 81-86

  Ecder, T ^a   Korular, D ^a   Gurevich, A K ^a   Weinberger, H D ^a   Schrier, R W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Heart failure; Ischemic heart disease; Myocardial infarction; Systolic dysfunction

Indexed keywords

AMLODIPINE; AMRINONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CARDIOVASCULAR AGENT; CARVEDILOL; DIGITALIS; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; ENALAPRIL; FUROSEMIDE; HYDRALAZINE; INOTROPIC AGENT; ISOSORBIDE DINITRATE; LISINOPRIL; LIXIVAPTAN; LOSARTAN; METOPROLOL; MILRINONE; PRAZOSIN; RAMIPRIL; SPIRONOLACTONE; UNINDEXED DRUG; VASODILATOR AGENT; VERAPAMIL;

AGING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIET RESTRICTION; DISEASE EXACERBATION; DRUG WITHDRAWAL; EXERCISE; EXERCISE TOLERANCE; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HYPERTENSION; META ANALYSIS; MORBIDITY; MORTALITY; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PATIENT EDUCATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; ULTRAFILTRATION; WEIGHT REDUCTION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DIURETICS; HEART FAILURE, CONGESTIVE; HUMANS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; VASODILATOR AGENTS;

EID: 0035154737     PISSN: 09678298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Trends in hospitalization rates for heart failure in the United States, 1973-1986: Evidence for increasing population prevalence
2. Evolving trends in the epidemiologic factors for heart failure: Rationale for preventive strategies and comprehensive disease management
3. Economic impact of heart failure in the United States: Time for a different approach
4. Prognosis in severe heart failure: Relation to hemodynamic measurements and ventricular ectopic activity
5. Long-term prognosis of patients presenting to the emergency room with decompensated congestive heart failure
6. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
7. The progression from hypertension to congestive heart failure
8. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy
9. Body fluid volume regulation in health and disease: A unifying hypothesis
10. Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure
11. Therapy of heart failure
12. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study
13. Chronic renal and neurohumoral effects of the calcium entry blocker nisoldipine in patients with congestive heart failure
14. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure
15. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction
16. Effect of amlodipine on morbidity and mortality in severe heart failure
17. A placebo-controlled trial of captopril in refractory chronic congestive heart failure
18. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
19. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
20. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
21. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
22. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure
23. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
24. A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
25. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction
26. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction
27. Follow-up study of patients randomly allocated ramipril or placebo for heart failure after acute myocardial infarction: AIRE Extension (AIREX) Study
28. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
29. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
30. The treatment of heart failure: Guidelines
31. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
32. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
33. Digitalis: Mechanisms of action and clinical use
34. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: Results of the PROVED trial
35. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors
36. The effect of digoxin on mortality and morbidity in patients with heart failure
37. Effect of oral milrinone on mortality in severe chronic heart failure
38. Xamoterol in severe heart failure
39. Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure: Lack of benefit compared with placebo
40. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure
41. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure
42. Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure
43. Diuretic efficacy of high dose furosemide in severe heart failure: Bolus injection versus continuous infusion
44. Diuretic resistance: Physiology and therapeutics
45. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure
46. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
47. Carvedilol produces dose related improvements in left ventricular function and survival in subjects with chronic heart failure
48. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure
49. The Cardiac Insufficiency Bisoprolol study II (CIBIS-II): A randomized trial
50. Effect of metoprolol CR/XL in chronic heart failure: Metopolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
51. Effects of beta-blocker therapy on mortality in patients with heart failure: A systematic overview of randomized controlled trials
52. Randomized trial of losartan versus captopril in patients over 65 with heart failure
53. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II
54. Angiotensin II receptor antagonists
55. Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study: The RESOLVD Pilot Study investigators
56. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
57. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients
58. Chronic administration of aldosterone depresses baroreceptor reflex function in the dog
59. 2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure
60. Endothelin in human congestive heart failure
61. Role of endothelin in the exercise intolerance of chronic heart failure
62. Endothelin receptor antagonists: Current status and perspectives
63. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group
64. Ultrafiltration in the treatment of refractory congestive heart failure
65. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: Failure of furosemide to provide the same result
66. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: Effects of extracorporeal ultrafiltration
67. Augmentation of coronary blood flow with intraaortic balloon pump counter-pulsation
68. Maximizing management of patients with decompensated heart failure
69. Permanent ventricular assist device support versus cardiac transplantation